等待开盘 10-17 09:30:00 美东时间
+0.535
+0.78%
康西哥涨3.56%;星座品牌涨3.28%;Blue Owl Capital Inc. Class A Common Stock涨2.66%
10-07 06:11
今日重点评级关注:JMP证券:维持Ocular Therapeutix"跑赢大市"评级,目标价从20美元升至29美元;汇丰银行:上调Banco BBVA Argentina评级至"买入",目标价从21美元下调至17美元
10-02 15:08
Cantor Fitzgerald analyst Richard Anderson initiates coverage on Ventas (NYSE:VTR) with a Overweight rating and announces Price Target of $77.
10-01 22:13
In the current session, the stock is trading at $69.20, after a 0.29% increase. Over the past month, Ventas Inc. (NYSE: VTR) stock increased by 1.88%, and in the past year, by 8.31%.
09-30 06:04
今日重点评级关注:Maxim Group:维持T Stamp"买入"评级,目标价从8美元升至12美元;Maxim Group:维持Rezolute"买入"评级,目标价从15美元升至20美元
09-22 18:44
Ventas (NYSE:VTR) declares $0.48/share quarterly dividend, in line with previous. Forward yield 2.82% Payable Oct. 16; for shareholders of record Sept. 30; ex-div Sept. 30. See VTR Dividend Scorecard,...
09-19 12:13
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
During the last three months, 8 analysts shared their evaluations of Ventas (NY...
09-16 04:00
Evercore ISI Group analyst Steve Sakwa maintains Ventas (NYSE:VTR) with a Outperform and raises the price target from $77 to $80.
09-15 22:21
今日重点评级关注:摩根大通:维持Futu Holdings"超配"评级,目标价从200美元升至270美元;Craig-Hallum:维持英伟达"买入"评级,目标价从195美元升至245美元
08-29 09:47